Delivery Order SPE2DB25D3012-SPE2DB25FXAKJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Qnasl 80 mcg nasal spray (10.6 grams) with a contract ceiling value of $2,486.72 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of June 2, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.30 to AmerisourceBergen Drug Corp for Qnasal 80 mcg nasal spray (10.6 grams) on September 10, 2025, with an ultimate completion date of September 11, 2025. This contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, where AmerisourceBergen maintains its corporate operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,542.48 to AmerisourceBergen Drug Corp for QNASL 80 MCG Nasal Spray (10.6 GM) with a completion deadline of September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the agency's medical supply chain operations. This delivery order...
- Amerisourcebergen Drug Corp has received a $3,391.17 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562699984 QNASL 80 MCG NASAL SPRAY 10.6GM. The delivery order was awarded on November 3, 2023 under an indefinite delivery contract with no set-aside designation used. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 6, 2023. As a leading pharmaceutical distributor,...
- This $1,717.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on June 12, 2024. The order is for the supply of 4564885519 QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product, with a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QNASL 80 MCG Nasal Spray 10.6GM, a prescription medication. The contract has a ceiling value of $3,011.73 and a completion date of December 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,349.47, is a delivery order for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a specialty medication. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $526,290 firm fixed-price delivery order to Amerisourcebergen Drug Corporation for 4561569109 QNASL 80 MCG nasal spray. The prime contractor will provide 10.6 grams of the nasal spray medication to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on July 24, 2023. No major subcontractors or set-aside designations were identified. The Defense...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $560 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 4561985611 QNASL 80 mcg nasal spray in 10.6 gram quantities. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 29, 2023 through August 30, 2023. No subcontractors or set aside designations were identified....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,325.92 contract is for the supply of QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product. The award has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAKJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Qnasl 80 mcg nasal spray (10.6 grams) with a ceiling value of $4,980.26. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medical products to support military and veteran healthcare systems through the Defense Health Agency and other government organizations. This particular delivery order for nasal spray medication falls within the company's established portfolio of pharmaceutical deliveries under the DLA Troop Support Medical contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The contract is scheduled for ultimate completion on September 23, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/22/25 |